The 3 Most Important Numbers on an Earnings Report

A quick look at Canopy Growth Corp’s (TSX:WEED(NYSE:CGC) recent quarterly results makes it easy to see why the stock has struggled over the past year.

| More on:

Cannabis stocks have been under the spotlight this year as poor earnings numbers have weighed heavily on the industry.

Canopy Growth Corp (TSX:WEED(NYSE:CGC) is a great example of a company that’s seen a big correction in recent months and could be in danger of falling further if it continues to underperform.

Below, I’ll look at what are three of the most important numbers investors should be looking at on earnings report and how they’ve affected Canopy Growth:

Sales

One of the most important numbers for any stock is how strong its sales have been. However, more than just overall sales, the company’s forecast for how it will do in future periods is critical.

One of the problems for Canopy Growth is that while the company has done a great job of growing its sales, it has been a bit too aggressive in making its projections.

Prior to legalization, then-CEO Bruce Linton once said he expected to see hundreds of retail stores in the company’s home province of Ontario being run by Canopy Growth, which just isn’t a possibility under the province’s current rules for pot shops. The retail model has struggled on many fronts and it has impacted many pot stocks in the industry.

But it’s not as simple as just sales growth as investors will be looking at comparables, and that means looking at organic sales growth.

Simply acquiring companies and being able to add their revenue into the mix isn’t going to be enough, investors are going to want to see that the business that was in place a year ago is doing better in the current year.

That’s why sales are evaluated against analyst expectations since they will take into account all of those factors.

Operating income

Many investors focus on net income or adjusted earnings figures, but the one that I find most reliable is a company’s operating income. Without the noise of net income or the subjectivity of adjusted earnings, operating income tells investors how profitable a company is from its day-to-day operations.

In Canopy Growth’s case, it would actually paint a bit of a better picture for the company, as over the past four quarters, its net loss of $1.9 billion has far outweighed its operating loss of $635k during that time.

However, it does give investors a glance at just how much of an impact taxes and non-operating items have been affecting the company’s bottom line.

Free cash flow

For me, the most important figure on a company’s earnings report is its free cash flow. Accounting income can often be misleading and fail to tell the whole story.

The amount of cash that the company is generating after its day-to-day operations and capital expenditures shows what kind of position it’s in and whether it can grow in the status quo or if it’ll need to raise funds.

Canopy Growth’s negative free cash of $1.4 billion over the trailing 12 months certainly raises some concerns. And while it may be able to benefit from having a big investor backing the company, it’s a sign that the company still has a long way to go in becoming a sustainable business.

Bottom line

There can be a lot of noise on a company’s earnings report, and by focusing on the three items above, investors can have a more accurate depiction of just how well a company did.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Farmer smiles near cannabis crop
Cannabis Stocks

TFSA Investors: An Undervalued Cannabis Stock You Can Buy for $500 Right Now

Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?

Down over 99% from all-time highs, Canopy Growth stock might recover in 2026 if the Trump administration reclassifies cannabis products.

Read more »

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis Surged 21% on Possible Cannabis Reclassification in the U.S. Is ACB Stock Finally a Good Buy?

Down almost 99% from all-time highs, Aurora Cannabis is a beaten-down marijuana stock that offers upside potential in December 2025.

Read more »

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »